The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105
Open Access
- 1 July 1998
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 188 (1) , 93-101
Abstract
The B cell–specific transmembrane protein RP-105 belongs to the family of Drosophila toll-like proteins which are likely to trigger innate immune responses in mice and man. Here we demonstrate that the Src-family protein tyrosine kinase Lyn, protein kinase C β I/II (PKCβI/II), and Erk2-specific mitogen-activated protein (MAP) kinase kinase (MEK) are essential and probably functionally connected elements of the RP-105–mediated signaling cascade in B cells. We also find that negative regulation of RP-105–mediated activation of MAP kinases by membrane immunoglobulin may account for the phenomenon of antigen receptor–mediated arrest of RP-105–mediated B cell proliferation.Keywords
This publication has 43 references indexed in Scilit:
- Molecular cloning of human RP105European Journal of Immunology, 1997
- Molecular Cloning of a Human RP105 Homologue and Chromosomal Localization of the Mouse and Human RP105 Genes (Ly64andLY64)Genomics, 1996
- An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAJournal of Laboratory and Clinical Medicine, 1996
- Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation.Journal of Experimental Medicine, 1996
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and FynCurrent Biology, 1993
- The CR2/CD19 complex on human B cells contains the src-family kinase LynInternational Immunology, 1993
- Signal Transduction Pathways Involved in B‐Cell InductionImmunological Reviews, 1993
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990